Executives On The Move: Changes At Amgen, Novartis and EyePoint
Amgen commercial lead takes up top sales post at Adamas Pharmaceuticals and a Novartis Oncology VP switches to SVP, Americas Commercial Oncology at Eisai Inc. Also, EyePoint Pharma announces its new chief commercial officer is now on board.
You may also be interested in...
Exits from Pfizer and Gilead as executives move to Oligomerix Inc. and Pandion Therapeutics, respectively, while chief medical officers are appointed at Exicure and Larimar Therapeutics Inc.
Executives On The Move: Exits At Allergan And Sanofi, And Wave Life Sciences Fills Newly Created Position
Artax Biopharma, focusing on autoimmune diseases, selects Sanofi Genzyme R&D SVP as its new CMO, and Allergan chief information officer accepts same post at Merck spin off Organon & Co. Also, genetic medicines company Wave Life Sciences fills newly created position of SVP of therapeutics discovery.
An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.